Efficacy And Safety Of injectable PRF As An Adjuvant with topical minoxidil In Treatment Of Male Patterned Baldness
Not Applicable
- Conditions
- Health Condition 1: L649- Androgenic alopecia, unspecified
- Registration Number
- CTRI/2023/08/056519
- Lead Sponsor
- Krishna Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Have given written consent before any treatment is commenced.
2. Be diagnosed to be suffering from male patterned baldness by assessment through Hamilton and Norwood Scale(Grade 2 to 6) clinically in DERMATOLOGY OPD
3. Have completed 18 years of age.
Exclusion Criteria
A. Patient having keloid scarring or keloidal tendency.
B. History of bleeding disorder and anticoagulant therapy.
C. Active skin infection over scalp.
D. Patient on any other systemic drugs therapy which in the judgement of investigator may interfere with interpretation of results.
E. Patients with known hypersensitivity to topical anaesthetic agents.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in hairlossTimepoint: Reduction in hairloss in 6 months
- Secondary Outcome Measures
Name Time Method identification of better adjuvantTimepoint: new hair growth in 6 months